Skip to main content

Table 1 Characteristic of studies included in the meta-analysis

From: Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies

Author

Year

Country

Study type

Mean age

Male (%)

Sample size

Category of exposure (N)

Outcome

Adjusted variable

NOS score

Chiranjeev Dash [13]

2014

US

retrospective

54.6 (8.5)

0 (0)

3668

T2DM (804)

CRA (917)

age, educational status, body mass index (weight (kg)/height (m)2), physical activity, family history of colorectal cancer in a first-degree relative, menopausal status, smoking status, alcohol intake, total energy intake, red meat intake, fruit and vegetable intake, and regular aspirin use

8

Heike Ursula [14]

2012

German

prospective

61.5

670 (62)

1554

T2DM (166)

Colorectal neoplasia (389)

age and sex

8

Tomomi Marugame [15]

2002

Japan

retrospective

52.4

1389 (100)

1389

Newly diagnosed T2DM (41)

CRA (560), Proximal adenomas(254), Distal adenomas (306)

hospital, rank in the Self Defense Forces, alcohol use, and cigarette smoking

7

Hongha T Vu [20]

2014

USA

retrospective

46

92 (36.8)

250

T2DM (125)

CRA (56)

ethnicity, body mass index, smoking, and alcohol use

7

Rodney Eddi [18]

2012

USA

retrospective

71

442 (56.4)

783

T2DM (89)

Adenomatous polyps (261)

Age, Sex, TG, LDL, HDL, Smoking, Family history of CRC, Aspirin, NSAID, Statins

7

Mehulkumar K. Kanadiya [19]

2013

American

retrospective

60.63(9.20)

1697 (49)

3465

T2DM (405)

CRA (852)

NA

3

Joseph Carl Anderson [35]

2011

USA

retrospective

NA

76 (38.0)

290

T2DM (46)

Any Sessile Serrated Adenomas (90)

NA

7

Bouwens, M [36]

2011

NA

retrospective

60

863

1836

T2DM

Combined adenoma-serrated phenotype (139)

NA

5a

de Kort, S [37]

2013

Netherlands

retrospective

NA

NA

3335

T2DM (326)

CRA (1112)

age, gender, BMI and other relevant risk factors

4a

Jill E. Elwing [38]

2006

US

retrospective

59.2

0 (0)

600

All diabetics (100)

Any Adenoma (159)

age, race, hypertension, hypercholesterolemia, BMI, and NSAID status

7

Advanced adenoma (46)

Kazushige Kawai [39]

2012

Japan

prospective

63.1(10.5)

109 (61.9)

176

T2DM (3888)

Polyp (69)

NA

7

Suminori Kono [40]

1998

Japan

retrospective

50–54

5193 (100)

5193

T2DM (166)

sigmoid colon adenomas (821)

body mass index (wt [kg]/ht [m]2), cigarette smoking, alcohol use, rank of the Self Defense Forces, and hospital.

7

Takasei Nishii [41]

2001

Japan

retrospective

48.4

951 (100)

951

T2DM (43)

Colon Adenomas(233)

Age- and BMI

6

Sunghwan Suh [42]

2011

Korea

retrospective

55.9

2528 (72.1)

3505

T2DM (509)

Multiple Adenomatous

sex, age, BMI, TC, HDL, TG, Fasting plasma glucose, HbA1c

7

Polyps (509)

Thomas R [43]

2012

NA

retrospective

58.4

1230 (95)

1295

T2DM (350)

Advanced adenoma (243)

NA

3a

Wang, JH [44]

2013

China

retrospective

NA

NA

470

T2DM

CRA(235)

abdominal circumference, daily calories & fat intake, increased diastolic blood pressure, history of hypertension or fatty liver, family history of cancer in digestive system, LDL and hsCRP, while female and daily fiber intake

6a

Misciagna, G [16]

2004

Italy

retrospective

57.5

154 (64.4)

239

Diabetes (34)/ Glucose (mg/100 ml)

CRA(153)

NA

8

  1. DM diabetes mellitus, T2DM type 2 diabetes mellitus, CRA colorectal adenoma, NSAID nonsteroidal anti-inflammatory drugs, TG serum cholesterol and triglycerides, BMI body mass index, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, hsCRP high-sensitivity C-reactive protein, T2DM non-insulin dependentdiabetes mellitus, TC total cholesterol, HDL high-density lipoprotein, NA not available
  2. a conference abstract